Maravai LifeSciences (MRVI) Tops Q2 EPS by 2c
Tweet
Share
E-mail
Get Alerts MRVI Hot Sheet
Join SI Premium – FREE
Maravai LifeSciences (NASDAQ: MRVI) reported Q2 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $51.4 million versus the consensus estimate of $48.68 million.
For earnings history and earnings-related data on Maravai LifeSciences (MRVI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pizza Hut CEO Aaron Powell resigns
- Dell Technologies (DELL) Tops Q2 EPS by $2.17, Offers Guidance
- MongoDB (MDB) Tops Q2 EPS by 29c, Beats on Revenue; Offers FY37 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
